Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830674 · ClinicalTrials.gov registry record · Phase 1
A Study of KRN23 in X-linked Hypophosphatemia
A Phase 1 study, sponsored by Kyowa Kirin Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT00830674 is a Phase 1 study that has completed, run by Kyowa Kirin Co.. The registered enrollment target is 42 participants.
The verdict
NCT00830674, a Phase 1 study, has completed, sponsored by Kyowa Kirin Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the safety and tolerability of KRN23 after a single intravenous (IV) and subcutaneous (SC) administration in XLH patients.
Interventions
- DRUG Placebo
- DRUG KRN23
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00830674
The ClinicalTrials.gov registry entry for NCT00830674 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Kirin Co., which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00830674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00830674 about?
NCT00830674 is a clinical study titled "A Study of KRN23 in X-linked Hypophosphatemia". The primary objective of this study is to assess the safety and tolerability of KRN23 after a single intravenous (IV) and subcutaneous (SC) administration in XLH patients.
What is the current status of trial NCT00830674?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2008-12. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00830674?
The interventions under investigation include: Placebo (DRUG), KRN23 (DRUG).
Who is sponsoring clinical trial NCT00830674?
This trial is sponsored by Kyowa Kirin Co., which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.